Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-02-09

Clinical Trial Update: TRIGEN SURESHOT™ Distal Targeting System Study [NA]

View source ↗

Summary

The trial evaluating the TRIGEN SURESHOT Distal Targeting System for a femoral shaft fracture has been terminated, with results posted on February 9, 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRIGEN SURESHOT Distal Targeting System

Snippet

Sponsor: Smith & Nephew, Inc. | Conditions: Femoral Shaft Fracture | NA | Status: TERMINATED | Results posted: 2016-02-09